溶解度
差示扫描量热法
溶解
共晶
材料科学
阿司匹林
水杨酸
傅里叶变换红外光谱
化学
热稳定性
色谱法
核化学
有机化学
化学工程
分子
氢键
生物化学
物理
工程类
热力学
作者
Braham Dutt,Manjusha Choudhary,Vikas Budhwar
出处
期刊:Research journal of pharmacy and technology
[Diva Enterprises Private Limited]
日期:2022-02-26
卷期号:: 768-772
被引量:2
标识
DOI:10.52711/0974-360x.2022.00128
摘要
Cocrystallization process is a well-known technique for altering the pharmaceutical properties of drugs without modifying their actual pharmacological actions. Availability of a number of potential coformers make this technique more useful for implementation in pharmaceutical research area on newer and older API’s having pharmaceutical issues like poor solubility, stability profiles etc. Aspirin is a long-known antipyretic and anti-inflammatory drug belonging to BCS Class II having poor aqueous solubility. This API undergoes hydrolysis at higher temperature and in humid environment with the resultant degradation products being salicylic acid and acetic acid. Cocrystalization technique could be useful for improving its stability profile as the physicochemical properties of drugs get modified by their cocrystallization with coformers having better thermal stability as well higher solubility profile than API’s. In this study, aspirin and benzoic acid have been cocrystallized in a fixed stochiometric ratio (1:2) for improving its stability issues. Differential Scanning Calorimetry (DSC), Infra-Red spectroscopy technique (FTIR) and X-ray Diffraction (XRD) technique were used for analysis of cocrystals. Dissolution study was performed which revealed an improved dissolution profile of cocrystals compared to pure drug aspirin. Accelerated stability study was performed as per ICH guidelines for 6 months and stability profile of drug and cocrystals were compared by using HPLC technique, which exhibited a better stability profile of cocrystals compared to pure drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI